Noleus Technologies

Sugar Land, United States Founded: 2015 • Age: 11 yrs
Developer of medical devices to reduce post-surgical swelling

About Noleus Technologies

Noleus Technologies is a Healthcare company based in Sugar Land (United States) founded in 2015 by Swarna Balasubramaniam. Developer of medical devices to reduce post-surgical swelling. Noleus Technologies has raised $3.08 million across 3 funding rounds from investors including MassChallenge. Its chief executive, as recorded, is Swarna Balasubramaniam. Its focus areas include Traditional Medical Devices.

Company details

Noleus Technologies was founded in 2015 and is based in Sugar Land, United States. Operations center on the healthcare sector, where platform technologies are developed and commercialized to address post-surgical swelling. An initial product is targeted at accelerating bowel function recovery after abdominal surgery, with proprietary designs intended for consistent application. Patient outcomes are improved through these mitigation efforts, establishing potential standards in post-operative care.

Key Metrics
  • Total Equity Funding
    $3.08M (USD)

    in 3 rounds

  • Latest Funding Round
    $2.2M (USD), Series A

    May 2021

  • Investors

Funding Insights of Noleus Technologies

Noleus Technologies has successfully raised a total of $3.08M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.2 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.08M
  • Total Rounds 3
  • Last Round Series A β€” $2.2M
  • First Round $880,000

    (Jun 2018)

  • Investors Count 1

All 3 funding rounds of Noleus Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2021$2.2MSeries A––
–
Sep 2019Grant––
Jun 2018$880,000Seed––
–
Valuation history

1 investors in total: 1 institutional.

Investors in Noleus Technologies

Noleus Technologies has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include MassChallenge.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Early-stage entrepreneurs are accelerated through MassChallenge's program.
masschallenge.orgBoston, United States
Premium access

Investor details for Noleus Technologies

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Noleus Technologies

2 people are tracked at Noleus Technologies (2 in leadership).

NameRoleGroup
Swarna Balasubramaniam
Founder & CEOLeadership
🦸♀️ Swarna Balasubramaniam, MD
Founder and CEOLeadership
Premium access

Complete people profiles for Noleus Technologies

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Noleus Technologies

3 dated milestones of Noleus Technologies across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Noleus Technologies is founded.
  2. Funding First funding round of $880K.
  3. Funding Latest funding round, Series A, of $2.2M.

Top companies in Traditional Diagnostics & Medical Devices

3 companies that operate in the same segment as Noleus Technologies (Traditional Diagnostics & Medical Devices) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Materials management solutions are provided for healthcare organizations.
1892Chicago, Illinois, United StatesUSD 29.13 MUSD 19.48 B95,424
3D-printed orthopedic products are manufactured for medical applications.
1941Kalamazoo, Michigan, United States
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Noleus Technologies

Noleus Technologies was founded in 2015 and raised its 1st funding round 3 years after it was founded.

Noleus Technologies is headquartered in Sugar Land, United States. It is registered at Sugar Land, Texas, United States.

Swarna Balasubramaniam is the CEO of Noleus Technologies, as recorded in our data. They have also founded this company.

Noleus Technologies is a funded company, having raised a total of $3.08M across 3 funding rounds to date. The company's 1st funding round was a Seed of $880K, raised on Jun 2018.

Noleus Technologies was founded in 2015 and is based in Sugar Land, United States. Operations center on the healthcare sector, where platform technologies are developed and commercialized to address post-surgical swelling. An initial product is targeted at accelerating bowel function recovery after abdominal surgery, with proprietary designs intended for consistent application. Patient outcomes are improved through these mitigation efforts, establishing potential standards in post-operative care.

Noleus Technologies has 1 investor. Key investors include MassChallenge.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available